Patent · US Active

Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin

US7273928B2 · kind B2 · utility

0Cited by

3References

21Claims

0Family size

Assignee

Biosyn Arzneimittel GmbH · DE

Inventors

Jürgen Markl · Gau-Bischofsheim, DE
Benjamin Altenhein · Wiesbaden, DE
Bernard Lieb · Mainz, DE
Thomas Stiefel · Stuttgart, DE

Key dates

Filing date	Aug 29, 2006
Grant date	Sep 25, 2007
Priority date	—
Expiry date	Aug 29, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/855
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A nucleic acid molecule or construct alone or with a promoter suitable for expression control is contemplated that codes for a HLH2 haemocyanin polypeptide and comprises at least one intron sequence, as well as haemocyanin fusion proteins. The construct further can comprise a nucleic acid sequence that codes for an antigen. Host cells are also contemplated that contain the nucleic acid molecules or construct and recombinant expression product thereof. The invention further relates to a pharmaceutical composition that comprises the expression product of that nucleic acid and antibodies obtainable by immunization of an animal therewith, as well as use of the antibodies in screening methods for the identification of tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.